1 completed, 1 recruiting, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow Adjuvant Chemoradiotherapy: new trials by email Literature Review of Adjuvant Chemoradiotherapy trials Research Report on Adjuvant Chemoradiotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC Nab-paclitaxel, cisplatin and Pembrolizumab combination, surgery, Adjuvant Chemoradiotherapy - Head and Neck Squamous Cell Carcinoma | Phase 2 | Recruiting | Guangdong Provincial People's Hospital | 86 | 2022-03-01 | 2025-07-01 |
| CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer Nivolumab, Surgery, Radiotherapy, Nivolumab, Surgery, Chemoradiotherapy - Squamous Cell Carcinoma of the Oral Cavity | Phase 2 | Completed | The Clatterbridge Cancer Centre NHS Foundation Trust | 21 | 2019-05-10 | 2025-02-25 |
| Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer Neoadjuvant chemoradiotherapy, Adjuvant chemoradiotherapy - Esophageal Cancer | Phase 2 | Unknown | Zhejiang Cancer Hospital | 60 | 2011-10-01 | 2013-05-14 |
Squamous Cell Carcinoma of Head and Neck (2) · Carcinoma, Squamous Cell (1) · Esophageal Neoplasms (1) · Head and Neck Neoplasms (1)
Guangdong Provincial People's Hospital (1) · The Clatterbridge Cancer Centre NHS Foundation Trust (1) · Zhejiang Cancer Hospital (1)
China (2) · United Kingdom (1)
Joseph Sacco, MBChB (1) · Weimin Mao, MD (1)
2017 (1)